… neurons. Because these differences can potentially be used to discover novel drugs for Parkinson’s disease, we would … the deficiencies of dopamine neurons with parkin mutations, compared to normal neurons. Relevance to Diagnosis/Treatment … the study will allow us to screen for novel therapeutic targets for Parkinson’s disease using cells that are most …

… Neurons of the substantia nigra are particularly vulnerable to cell death in Parkinson’s disease (PD). One potential … potential to identify a biochemical pathway that can be targeted to prevent and/or slow the progression of neuronal cell loss in PD. Anticipated Outcome:           If we find that this particular molecule is …

… opinions about receiving research test results that relate to a person’s known diagnosis, like Parkinson disease. It … different kinds of research test results. This will let us get opinions from a broader group of people. We will then … test results with participants. Research can then study how people respond to learning expected and unexpected test …

… Starting November 1, we asked our community to grab the megaphone and rally their family and friends to … their best "unselfies," many of our crowdfunders proudly showed off their support on social:         Until a cure is …

… for Parkinson’s Research (MJFF) announced $1.2 million in total awards to four research teams working to advance … plc (NYSE: ELN), a neuroscience-based biotechnology company. "For successful translation into real-world PD … see if they can reduce deficits seen in animal models. Neil Howell, PhD, of San Diego-based MIGENIX Corporation will …

… develops in part because brain cells lose the ability to clear away damaged proteins and cell parts, leading to … cell death. A gene called LRRK2, which is one of the most common genetic causes of Parkinson’s, makes this problem … Rubicon levels using modern genetic tools, I will measure how well cells can recycle damaged proteins, clear toxic …